[Effect of a benzopyrone compound on liver function. Short communication (author's transl)].
The results of the presented double-blind trial proved that the benzopyrone compound Venalot, a combination of coumarin and troxerutin used in the treatment of local inflammatory oedemas of traumetic, phlebopathic and lymphostatic origin, can be administered unhestitatingly in case of severe parenchymatous liver damages even in a dosage which was chosed higher than that recommended and usually given (2 depot tablets b.d.).
D000328:Adult; D000368:Aged; D003374:Coumarins / Q000008:administration & dosage / Q000009:adverse effects*; D004338:Drug Combinations; D004487:Edema / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D006896:Hydroxyethylrutoside / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D008099:Liver / Q000187:drug effects*; D008107:Liver Diseases / Q000097:blood / Q000150:complications; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D012431:Rutin / Q000031:analogs & derivatives*
D003374:Coumarins; D004338:Drug Combinations; D006896:Hydroxyethylrutoside; D012431:Rutin
Die Wirkung eines Benzopyron-Präparates auf die Leberfunktion. Kurze Mitteilung